Ocugen announces FDA alignment for Phase 2/3 trial of gene therapy OCU410ST for Stargardt disease, showing promising initial results. Ocugen, Inc. announced it has received FDA approval to proceed ...
Luci indicated the company is focused on securing additional funding opportunities to support the Phase 3 ibezapolstat clinical trial program and expects further updates on funding initiatives in ...
SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...
Diamyd Medical has reached alignment with the U.S. Food and Drug Administration (FDA) to accelerate the primary efficacy readout in its ongoing pivotal ...
At the 18th Annual Ambulatory Surgery Centers Conference in Chicago on Oct. 28, Kate Lovrien, senior manager, and Luke Peterson, national director of the strategy group, Kurt Salmon Associates, ...
What just happened? NASA recently completed a series of critical mirror alignment steps on the James Webb Space Telescope. During the "fine phasing" stage, NASA had to check and test every optical ...
The Webb telescope has completed the third stage in aligning its mirrors, a crucial process for getting state-of-the-art imagery out of this $10 billion space telescope. The feat comes right on time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback